Keyphrases
Mycosis Fungoides
89%
Pemphigus Vulgaris
72%
Cutaneous Leishmaniasis
46%
Psoriasis
44%
Ultraviolet-B (UV-B)
44%
Atopic Dermatitis
38%
Israel
37%
Retrospective Cohort Study
27%
Sodium Stibogluconate
27%
Bullous Pemphigoid
27%
Pediatric Patients
23%
Methotrexate
22%
Dermatologist
21%
Primary Cutaneous B-cell Lymphoma
21%
MicroRNA
21%
Leishmania Braziliensis
20%
Narrowband UVB
20%
Clinical Treatment
20%
Clinical Characteristics
19%
Late-onset
19%
Phototherapy
19%
Rituximab
18%
Remission
18%
Treatment Options
18%
Travellers
18%
Keratinocytes
18%
Treatment Response
18%
Melanoma
18%
Liposomal Amphotericin B
17%
Autoimmune Disease
17%
Tumor
16%
Alopecia Areata
16%
Biopsy Specimen
16%
Tinea Capitis
16%
Illness Perceptions
16%
Prognostic Factors
15%
Scalp
15%
Disease Severity
15%
Leishmania Major
15%
Leishmania Tropica
15%
Complete Remission
14%
Prednisone
14%
Onychomycosis
14%
Tertiary Care Hospital
14%
Clinical Course
14%
Immunohistochemical Study
14%
Complete Response
14%
Pemphigus
14%
Quality of Life
13%
Malignancy
12%
Medicine and Dentistry
Disease
100%
Mycosis fungoides
92%
Pemphigus vulgaris
45%
Cutaneous Leishmaniasis
43%
Psoriasis
38%
Retrospective Study
36%
Retrospective Cohort Study
32%
Neoplasm
31%
Nodular Melanoma
29%
Dermatosis
26%
Biopsy
25%
Pediatrics Patient
22%
Adverse Event
22%
B-Cell Lymphoma
22%
Sodium Stibogluconate
22%
Disease Course
21%
Bullous Pemphigoid
21%
Chronic Urticaria
21%
Infection
20%
Cancer
19%
Atopic Dermatitis
19%
Pediatrics
18%
Rituximab
18%
Erythema
17%
microRNA
16%
Phototherapy
16%
Psoralen
16%
Scalp
16%
Erysipelas
16%
Tinea Capitis
16%
Dermatology
15%
Leishmania Major
14%
Systemic Therapy
14%
Histopathology
14%
Lymphocyte
14%
PUVA
14%
Autoimmune Disease
13%
Side Effect
13%
Malignant Neoplasm
13%
Pemphigus
13%
B Cell
12%
Cohort Analysis
12%
Leishmania braziliensis
12%
Subcutaneous Nodule
12%
Amphotericin B
12%
Adolescent
12%
Treatment Response
12%
Skin Defect
12%
Cross Sectional Study
12%
Skin Infection
12%